Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, LIC, SBS

vCita's Clients Expected to Win More Business with Latest "Reserve with Google" Integration


SEATTLE and TEL AVIV, Israel, Jan. 9, 2019 /PRNewswire/ -- vCita, a leading cloud-based client engagement app for small businesses, has partnered with Google to help vCita clients get more direct bookings through Google search.

Launched in October 2017, "Reserve with Google" allows Google users to book appointments with nearby service providers directly through Google search. The service creates a simplified, direct sales channel by displaying a "book now" button next to the business' Google listing.

vCita clients who get listed with "Reserve with Google" will win massive exposure to millions of Google users who search for local service providers daily.

Bookings coming in through "Reserve with Google" will be automatically displayed on the vCita calendar, and vCita clients will be able to engage, market to, and manage appointments booked via "Reserve with Google" directly from the vCita platform. With "Reserve with Google" being a free service, vCita clients will be enjoying a new source of clients, without having to spend a single dollar on buying qualified leads.

vCita's latest integration with "Reserve with Google" is yet another step in the company's commitment to help small businesses prosper in a digital, mobile-first business environment. vCita's CEO, Itzik Levy, explained the importance of small businesses tapping into the mobile space:

"Consumers today expect instant, gratifying, mobile-based experiences. vCita helps small businesses bridge the digital gap by turning every online asset that they own into an active selling and servicing point. 'Reserve with Google' is an exciting addition to the vCita toolbox of marketing and business management capabilities, making small business owners that much more successful".

About vCita

vCita was founded with the vision that small business owners deserve better, more fulfilling workdays. We develop smart, cloud-based, workday solutions that help soloprenures and small teams manage their entire business from a single, easy-to-use, on-the-go app. Our solution turns time-consuming tasks like scheduling, payments, collection and marketing campaigns into simple, one-click operations. vCita covers and manages the entire customer life-cycle, from the first "hello" to the final invoice, giving business owners the freedom to enjoy their work, while growing their business.

vCita has offices in Bellevue, Washington, and Tel-Aviv.

Visit us: on our blog, Facebook, Twitter and LinkedIn

PR contact: Talya Fuksman, [email protected] 

SOURCE vCita


These press releases may also interest you

at 08:45
HYAS Infosec, the adversary infrastructure platform provider that offers unparalleled visibility, protection, and security against all kinds of malware and attacks, today announced that it has been awarded three top recognitions from Security Today's...

at 08:44
Understanding the underlying mechanisms of normal and pathological cellular processes is essential for developing new drugs. Fortunately, modern techniques and experimental methods have greatly accelerated progress. The latest issue of JPA features...

at 08:44
Environmental problems caused by population explosion such as global warming, natural resource depletion, deforestation, water shortage and plastic pollution are getting severe in the world. Regarding plastic pollution, micro-plastics, nano-plastics...

at 08:43
WIN (Women In Negotiation) is pleased to announce Walmart Connect as its presenting sponsor - for its eighth annual WIN Summit to be held Thursday, May 30, 2024 in New York City....

at 08:40
The "Global Cell Counting Market: Analysis By Product, By Application, By End-User, By Region Size, Trends and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The global cell counting market was valued at US$9.98...

at 08:40
Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their...



News published on and distributed by: